We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
235 hedge funds and large institutions have $5.32B invested in MyoKardia, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 98 increasing their positions, 51 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
156% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 27
131% more capital invested
Capital invested by funds: $2.3B → $5.32B (+$3.01B)
92% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 51
63% more funds holding in top 10
Funds holding in top 10: 8 → 13 (+5)
21% more funds holding
Funds holding: 194 → 235 (+41)
36% less call options, than puts
Call options by funds: $30.6M | Put options by funds: $48M
Holders
235
Holders Change
+41
Holders Change %
+21.13%
% of All Funds
4.82%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.27%
New
69
Increased
98
Reduced
51
Closed
27
Calls
$30.6M
Puts
$48M
Net Calls
-$17.4M
Net Calls Change
-$23M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$116M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$77.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$46M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.4M |
